Childrens Hospital Oakland

Oakland, California 94618

1 studies enrolling now · 35 studies all time

What they study most

Abortion Early, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Anemia, Anemia, Aplastic, Anemia, Cooley's, Anemia, Diamond-Blackfan, Anemia, Sickle Cell, Atrial Septal Defect, Beta-Thalassemia, Beta-thalassemia, Bronchopulmonary Dysplasia

Studies at this site

• A Pediatric and Young Adult Trial of Genetically Modified T Cells Directed Against CD19 for Relapsed/Refractory CD19+ Leukemia — Running, not enrolling
• A Study of Guselkumab in Pediatric Participants With Moderately to Severely Active Ulcerative Colitis — Running, not enrolling
• A Study Evaluating the Efficacy and Safety of Mitapivat in Participants With Transfusion-Dependent Alpha- or Beta-Thalassemia (α- or β-TDT) — Running, not enrolling
• A Study Evaluating the Efficacy and Safety of Mitapivat (AG-348) in Participants With Sickle Cell Disease (RISE UP) — Running, not enrolling
• PNOC 001: Phase II Study of Everolimus for Recurrent or Progressive Low-grade Gliomas in Children — Completed
• KIR Favorable Mismatched Haplo Transplant and KIR Polymorphism in ALL/AML/MDS Allo-HCT Children — Enrolling by invitation
• Mail Order Mifepristone Study — Completed
• Safety and Dose Ranging Study of Insulin Receptor MAb-IDUA Fusion Protein in Patients With MPS I — Completed
• Efficacy and Safety of Ferriprox® in Patients With Sickle Cell Disease or Other Anemias — Stopped early
• Study for Transfusionally Iron Overloaded Children, Adolescents and Adults Using FBS0701 (SSP-004184) — Stopped early
• Study of GA-GCB Enzyme Replacement Therapy in Type 1 Gaucher Disease Patients Previously Treated With Imiglucerase — Completed
• Iduronate-2-sulfatase Enzyme Replacement Therapy in Mucopolysaccharidosis II (MPS II) — Completed
• An Open-Label Extension Study of GA-GCB ERT in Patients With Type 1 Gaucher Disease — Completed
• Trial of Late Surfactant to Prevent BPD: A Pilot Study in Ventilated Preterm Neonates Receiving Inhaled Nitric Oxide — Completed
• Bone Health in Pregnancy — Completed
• A Treatment Study of Mucopolysaccharidosis Type IIIB — Completed
• A Study of UX003 Recombinant Human Beta-Glucuronidase (rhGUS) Enzyme Replacement Therapy in Subjects With Mucopolysaccharidosis Type 7, Sly Syndrome (MPS 7) — Completed
• A Phase 3 Study of UX003 Recombinant Human Betaglucuronidase (rhGUS) Enzyme Replacement Therapy in Patients With Mucopolysaccharidosis Type 7 (MPS 7) — Completed
• Nitric Oxide Inhalation to Treat Sickle Cell Pain Crises — Completed
• Closure of Atrial Septal Defects With the AMPLATZER Septal Occluder - Post Approval Study — Completed
• Phase I Study on Rivaroxaban Granules for Oral Suspension Formulation in Children — Completed
• Safety and Dose Ranging Study of Insulin Receptor MoAb-IDS Fusion Protein in Patients With Hunter Syndrome — Completed
• Study of Deferasirox in Iron Overload From Beta-thalassemia Unable to be Treated With Deferoxamine or Chronic Anemias — Completed
• Study of Pancreatic Enzyme Product in Pediatric Participants With Cystic Fibrosis and Exocrine Pancreatic Insufficiency — Completed
• Cord Blood Transplantation for Sickle Cell Anemia and Thalassemia — Completed
• Establishing a Repository of Blood and DNA Samples From People With Sickle Cell Disease (Comprehensive Sickle Cell Centers Collaborative Genotype-Phenotype Database and Sample Repository) — Stopped early
• Sildenafil Therapy for Pulmonary Hypertension and Sickle Cell Disease — Stopped early
• ENTRUST, a 5 Year Surveillance of Children Aged 2 to <6 Years With Transfusional Iron Overload Treated With Deferasirox — Completed
• Arginine Treatment of Acute Chest Syndrome (Pneumonia) in Sickle Cell Disease Patients — Completed
• iScreen Study: Best Methods for Social Screening in Pediatric Caregivers — Completed
• Thalassemia (Cooley's Anemia) Clinical Research Network (TCRN) — Completed
• Safety & Efficacy of ICL670 vs. Deferoxamine in Beta-thalassemia Patients With Iron Overload Due to Blood Transfusions — Completed
• A Phase 4 Two Dose Level Study of Naglazyme(TM) (Galsulfase) in Infants With MPS VI — Completed
• Study of Deferasirox Relative to Subcutaneous Deferoxamine in Sickle Cell Disease Patients — Completed
• A Study Evaluating the Long-Term Safety of ICA-17043 in Sickle Cell Disease Patients With or Without Hydroxyurea Therapy — Stopped early